| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers T > Headlines for Tenders 2009 > News item |
Enzon buys back $76.9 million of convertibles in 2008
By Angela McDaniels
Tacoma, Wash., Feb. 19 - Enzon Pharmaceuticals, Inc. said it repurchased $76.9 million of convertible debt during 2008.
The debt repurchased included $4.5 million of Enzon's 4% convertible senior notes due 2013, according to its earnings report.
The company previously reported that it had $72.4 million of convertibles maturing in 2008.
Under current liabilities, the company listed $2.95 million of notes payable as of Dec. 31, down from $72.39 million as of Dec. 31, 2007. Its total amount of notes payable was $267.55 million at Dec. 31, compared with $275 million a year earlier.
Enzon is a Bridgewater, N.J.-based biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.